• Login
    View Item 
    •   USU-IR Home
    • Faculty of Medicine
    • Master Theses (Clinical Medicine)
    • View Item
    •   USU-IR Home
    • Faculty of Medicine
    • Master Theses (Clinical Medicine)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Hubungan Kadar Interleukin-6 (IL-6) dengan Tingkat Keparahan pada Pasien Covid di Rumah Sakit Umum Pusat Haji Adam Malik

    Thumbnail
    View/Open
    Cover (347.8Kb)
    Fulltext (2.493Mb)
    Date
    2023
    Author
    Kardiasyah, Alzi
    Advisor(s)
    Syarani, Fajrinur
    Bihar, Syamsul
    Metadata
    Show full item record
    Abstract
    Background: Understanding of epidemiology, clinical appearance, laboratory tests, diagnosis, and treatment is still developing. 1 The results of laboratory tests on several markers of inflammation have been shown to correlate with the severity of COVID-19 such as lymphopenia, high D-dimer, T lymphocytes, IL-1 and IL -6. Methods: This research is an analytical research with cross-sectional, data collected through interviews and questionnaires, analyzed with chi-square by SPSS 25. The research participant is a healthworker at the Adam Malik Haji Hospital which is the survivors of Covid-19 in 2020-2022. Result: Increase in Interleukin - 6 is the age group of 60-69 years (39.50%), half of the study subjects are female (52.6%), the clinical degree of COVID-19 patients consists of category 5 (40.8%), category 6 (31.6%), category 7 (18.4%) and category 4 (9.2%). The results of this study found that the group with the most Interleukin-6 levels was 7-50 pg/mL (48.7%), The group requiring oxygen therapy consisted of NRM (44.7%). This study found that all study subjects had comorbidities, 1 comorbid (76.3%), the risk opportunity for Interleukin-6 levels was >50 pg/mL related to the degree of severity category 6 (OR = 2.23, 95% CI 1.21-7.32). showed Interleukin levels - 6 > 50 pg/mL related to the need for oxygen therapy NRM (OR = 3.33 95% CI 2.03-4.51). Conclusion: The characteristics of the COVID-19 patients treated are mostly women, aged 60-69 years, a clinical grade above category 5, requiring oxygen therapy, almost half with Interleukin-6 levels ≥ 10 -g/m, and having at least 1 comorbid. High Interleukin-6 levels significantly increase the risk of a more severe clinical degree in COVID-19 patients. High Interleukin-6 levels significantly increase the risk opportunity for the level of need for oxygen therapy using NRM, HFNC and ventilators in COVID-19 patients being treated at Hj Adam Malik General Hospital Medan.
    URI
    https://repositori.usu.ac.id/handle/123456789/88490
    Collections
    • Master Theses (Clinical Medicine) [1506]

    Repositori Institusi Universitas Sumatera Utara - 2025

    Universitas Sumatera Utara

    Perpustakaan

    Resource Guide

    Katalog Perpustakaan

    Journal Elektronik Berlangganan

    Buku Elektronik Berlangganan

    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    Atmire NV
     

     

    Browse

    All of USU-IRCommunities & CollectionsBy Issue DateTitlesAuthorsAdvisorsKeywordsTypesBy Submit DateThis CollectionBy Issue DateTitlesAuthorsAdvisorsKeywordsTypesBy Submit Date

    My Account

    LoginRegister

    Repositori Institusi Universitas Sumatera Utara - 2025

    Universitas Sumatera Utara

    Perpustakaan

    Resource Guide

    Katalog Perpustakaan

    Journal Elektronik Berlangganan

    Buku Elektronik Berlangganan

    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    Atmire NV